Related Experiment Video
Updated: Feb 2, 2026

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
1.5K
Why and how to treat Ph-like ALL?
1Department of Pathology, St Jude Children's Research Hospital, 262 Danny Thomas Place, MS342, Memphis, TN, 38105, USA.
Best Practice & Research. Clinical Haematology
|November 24, 2018
Summary
Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a high-risk subtype. Targeted therapies, including tyrosine kinase inhibitors, show promise for treating specific genetic alterations in Ph-like ALL.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a high-risk subtype of B-cell precursor ALL.
- It shares a gene expression profile with Ph-positive ALL, has frequent IKZF1 alterations, and a poor prognosis.
- Ph-like ALL affects all age groups, with prevalence increasing in young adults.
Purpose of the Study:
- To review the genetic landscape of Ph-like ALL.
- To discuss targeted therapeutic strategies based on identified genetic alterations.
- To highlight the development of diagnostic screening and precision medicine trials.
Main Methods:
- Review of preclinical studies and anecdotal reports.
- Analysis of genetic alterations in Ph-like ALL.
- Examination of targeted therapy approaches.
Main Results:
- Ph-like ALL harbors diverse genetic alterations activating cytokine receptor and kinase signaling.
- Alterations fall into two main groups: ABL-class or JAK-STAT pathway activation.
- ABL-class fusions may respond to ABL1-inhibitors; JAK-STAT alterations to JAK inhibitors.
Conclusions:
- Ph-like ALL is a heterogeneous subtype requiring targeted treatment strategies.
- Precision medicine approaches, including tyrosine kinase inhibitors, are crucial for improving outcomes.
- Ongoing diagnostic screening and clinical trials aim to optimize chemotherapy combined with targeted therapies.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.3K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.3K
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Induced Pluripotent Stem Cells
28.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Bacterial Transformation
59.9K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.9K
Metal-Ligand Bonds
24.3K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.3K
Qualitative Analysis
24.3K
For solutions containing mixtures of different cations, the identity of each cation can be determined by qualitative analysis. This technique involves a series of selective precipitations with different chemical reagents, each reaction producing a characteristic precipitate for a specific group of cations. Metal ions within a group are further separated by varying the pH, heating the mixture to redissolve a precipitate, or adding other reagents to form complex ions.
For instance, group IV...
For instance, group IV...
24.3K

